Examples of 'antimitotic' in a sentence
Meaning of "antimitotic"
Antimitotic: Refers to substances or drugs that inhibit or prevent the process of mitosis (cell division), often used in cancer treatment to target rapidly dividing cancer cells
Show more definitions
- Preventing or disrupting mitosis.
- An agent that prevents or disrupts mitosis.
How to use "antimitotic" in a sentence
Basic
Advanced
antimitotic
Many antimitotic drug products are known to be embryotoxic.
Because of these interactions it is considered an antimitotic drug.
It has strong antimitotic activity by inhibiting polymerization of tubulin.
Plant virus particles for delivery of antimitotic agents.
Lignans also have antimitotic and fungicidal activity.
Its subject is also their use as hepatoprotective or antimitotic medicaments.
This antimitotic agent is selective for tumour cells.
Docetaxel and paclitaxel are antimitotic agents.
Most antimitotic compounds interact with the microtubule cytoskeleton.
Any treatment known for its antimitotic effect can be used.
Antimitotic agents can block the cell cycle during cell differentiation.
Lunasin is the first antimitotic peptide whose gene has been cloned.
The appropriate dosing regimen depends on the particular antimitotic employed.
It is a preferred antimitotic compound due to its microtubule stabilizing action.
Amikhelline is an antimitotic drug.
See also
Local antimitotic and cytotoxic.
This is an excellent antimitotic.
Several classes of antimitotic agents have been developed as anticancer agents.
The products of the present invention are therefore endowed with antimitotic properties.
The antimitotic agent disclosed herein but not claimed can also be an epothilone.
The ovarian tumour may be insensitive to treatment with one or more antimitotic drugs.
It is possible that all antimitotic agents may damage vascular endothelium leading to cardiac ischemia.
The synthesized compounds present an analogy with nucleotidic bases and are potentially antimitotic substances.
That a lower dose of antimitotic is used oftentimes lessens the side effects observed in a subject.
This compound has been revealed to be a potent antimitotic agent Hung DT et al.
Docetaxel is a chemotherapeutic antimitotic clinical drug that works by interfering with the multiplication of cells.
We confirm that lysosomal processing is essential for the antimitotic effect induced by IC treatment.
Antimitotic Drugs that arrest cell division.
However also tubulisine A has shown interesting antimitotic properties and promising antiangiogenic effects.
The role of β-tubulin isotypes in resistance to antimitotic drugs.
In some specific aspects the antimitotic agent stabilizes the mitotic spindle microtubule assembly.
In some embodiments, the chemotherapeutic agent is an antimitotic alkaloid.
Additionally, antimitotic agents are not typically recommended during pregnancy.
Solamargine and solasonine have an antibacterial effect, while solanine is antimitotic.
In a particular embodiment, the antimitotic vinca alkaloid is vincristine.
Recently, antimitotic drugs such as paclitaxel have received renewed interest.
Said active ingredient may in particular consist of an antibiotic and / or an antimitotic.
In some specific aspects, the antimitotic agent is paclitaxel or docetaxel.
Antimitotic agents are anti-cancer agents that inhibit the function of microtubules.
In a preferred aspect of the present invention, the antimitotic alkaloid is vinorelbine.
However, antimitotic colchicine is used only in research due to its toxicity.
Congenital or acquired immune deficiency ( including patients receiving immunosuppressive or antimitotic drugs ).
The antimitotic agent is preferably a taxane, preferably paclitaxel or a derivative thereof such as docetaxel.
Thus, the antitumor response mediated by taxol is due to its antimitotic activity.
Antimitotic agents include vincristine and vinblastine ( which are commonly referred to as vinca alkaloids ).
In one aspect of the disclosure, the antimitotic agent is a microtubule inhibitor or a mictrotubule stabilizer.
Any value below 10 µM indicates a potent antimicrotubule agent with significant antimitotic potential.
These concentrations of the antimitotic were also applied on apical and lateral microcuttings for 48 hours.
Therefore these peptides do not appear to cause the side-effects of existing antimitotic molecules.
Disclosed herein but not claimed, the antimitotic agent is a microtubule inhibitor or a mictrotubule stabilizer.
